NCT03924180 - Glytactin EfficiEncy in Non or Insufficiently Treated Adult PHENylketonuria Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

March 14, 2022

Study Completion Date

September 5, 2022

Conditions

Adult Phenylketonuria Non Treated Patients

Interventions

DIETARY_SUPPLEMENT

Dietary Supplement for PKU patients

For both treatment groups, the objective in total protein will be 1g / kg / day of ideal weight, in 3-6 doses / day, including natural proteins and supplemented by the products under study.

Trial Locations (7)

29609

CHU du Morvan-Département de Pédiatrie et génétique médicale,, Brest

35203

CHU-RENNES-Hôpital Sud-Service de Génétique-Clinique, Rennes

37044

CHRU-Hôpital Bretonneau - Service de Médecine Interne-Nutrition, Tours

44000

CHU-Service de Réanimation Pédiatrique / Néonatalogie, Consultation spécialisée en Maladies Héréditaires du Métabolisme, Nantes

49933

CHU-ANGERS -Médecine Interne, Angers

59037

CHU de LILLE-Hôpital Claude HURIEZ-Service d'Endocrinologie, Lille

69677

Hôpital Femme-Mère-Enfant-Centre de Référence des Maladies Héréditaires du Métabolisme de Lyon, Bron

All Listed Sponsors

lead

University Hospital, Tours

OTHER